Llwytho...
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
Inflammatory bowel diseases, such as ulcerative colitis and Crohn’s disease, are disabling conditions characterised by chronic, relapsing inflammation of the gastrointestinal tract. Current treatments are not universally effective or, in the case of therapeutic antibodies, are hampered by immune res...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Crohns Colitis |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5881740/ https://ncbi.nlm.nih.gov/pubmed/28158411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjx003 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|